• Home
  •  / Verseau Therapeutics

Verseau Therapeutics

OverviewSuggest Edit

Verseau Therapeutics is a company that develops macrophage checkpoint modulators designed to benefit patients with cancer, immune and inflammatory diseases. Its modulators identify novel targets and develop therapies that shift macrophages between immune activators and silencers in disease, enabling physicians to benefit patients from immunotherapy.
TypePrivate
Founded2017
HQBedford, MA, USMap
Websiteverseautx.com
View Jobs

Locations

Verseau Therapeutics is headquartered in
Bedford, United States

Location Map
All Locations (1)

Latest Updates

Employees (est.) (Apr 2022)16
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Verseau Therapeutics

John Edwards

John Edwards

Chief Executive Officer
Igor Feldman

Igor Feldman

Co-Founder and Chief Analytics Officer
Tatiana Novobrantseva

Tatiana Novobrantseva

Co-Founder and Chief Scientific Officer
Tim Smith

Tim Smith

Chief Business Officer
Daniel Anderson

Daniel Anderson

Director
Show more

Verseau Therapeutics Office Locations

Verseau Therapeutics has an office in Bedford
Bedford, MA, US (HQ)
47 Wiggins Ave
Show all (1)

Verseau Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2017

Verseau Therapeutics total Funding

$50 m

Verseau Therapeutics latest funding size

$50 m

Time since last funding

3 years ago

Verseau Therapeutics investors

20/20 HealthCare Partners, Highlight Capital, Alexandria Venture Investments, Yonghua Capital, 3sbio, InHarv Partners, The Mark Foundation for Cancer Research
Verseau Therapeutics's latest funding round in October 2019 was reported to be $50 m. In total, Verseau Therapeutics has raised $50 m
Show all financial metrics

Verseau Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

Learn more about our premium products
SecurityScorecard logo

Verseau Therapeutics Online and Social Media Presence

Verseau Therapeutics's Trends

Embed Graph

 Verseau Therapeutics Frequently Asked Questions

  • When was Verseau Therapeutics founded?

    Verseau Therapeutics was founded in 2017.

  • Who are Verseau Therapeutics key executives?

    Verseau Therapeutics's key executives are John Edwards, Igor Feldman and Tatiana Novobrantseva.

  • How many employees does Verseau Therapeutics have?

    Verseau Therapeutics has 16 employees.

  • Who are Verseau Therapeutics competitors?

    Competitors of Verseau Therapeutics include Ionova Life Science, Intrepida Bio and FoRx Therapeutics.

  • Where is Verseau Therapeutics headquarters?

    Verseau Therapeutics headquarters is located at 47 Wiggins Ave, Bedford.

  • Where are Verseau Therapeutics offices?

    Verseau Therapeutics has an office in Bedford.

  • How many offices does Verseau Therapeutics have?

    Verseau Therapeutics has 1 office.